Pfizer (PFE) Tops Q3 EPS by 13c, Raises FY Guidance

Pfizer (NYSE: PFE) reported Q3 EPS of $0.75, $0.13 better than the analyst estimate of $0.62. Revenue for the quarter came in at $12.7 billion versus the consensus estimate of $12.26 billion.

GUIDANCE:

Pfizer sees FY2019 EPS of $2.94-$3.00, versus the consensus of $2.82. Pfizer sees FY2019 revenue of $51.2-52.2 billion, versus the consensus of $51.32 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Pfizer's Litfulo meets Phase 3 endpoints for vitiligo treatment
• Onto Innovation gains on bullish RBC initiation citing advanced packaging growth
• Piper Sandler on Virtu Financial (VIRT): 'The most overlooked name in our coverage'